Home  »  Industry   »  Amylyx Pharmaceuticals Inc. (AMLX) Stock Could Soo...

Amylyx Pharmaceuticals Inc. (AMLX) Stock Could Soon Reward Patient Investors

Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) is -7.71% lower on its value in year-to-date trading and has touched a low of $6.51 and a high of $41.93 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AMLX stock was last observed hovering at around $31.17 in the last trading session, with the day’s gains setting it 2.93%.

Currently trading at $34.10, the stock is -1.41% and -5.29% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.11 million and changing 9.40% at the moment leaves the stock 15.18% off its SMA200. AMLX registered 22.62% gain for a year compared to 6-month gain of 21.27%.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


The stock witnessed a 0.00% loss in the last 1 month and extending the period to 3 months gives it a -4.35%, and is -5.07% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.21% over the week and 6.38% over the month.

Amylyx Pharmaceuticals Inc. (AMLX) has around 205 employees, a market worth around $2.44B and $0.30M in sales. Distance from 52-week low is 423.81% and -18.67% from its 52-week high. The company has generated returns on investments over the last 12 months (54.70%).

The EPS is expected to shrink by -108.00% this year.

Amylyx Pharmaceuticals Inc. (AMLX) Top Institutional Holders

The shares outstanding are 58.53M, and float is at 49.98M with Short Float at 10.93%.

Amylyx Pharmaceuticals Inc. (AMLX) Insider Activity

A total of 13 insider transactions have happened at Amylyx Pharmaceuticals Inc. (AMLX) in the last six months, with sales accounting for 2 and purchases happening 11 times. The most recent transaction is an insider sale by Morningside Venture Investment,the company’s10% Owner. SEC filings show that Morningside Venture Investment sold 50,000 shares of the company’s common stock on Mar 02 at a price of $33.75 per share for a total of $1.69 million. Following the sale, the insider now owns 7.48 million shares.

Amylyx Pharmaceuticals Inc. disclosed in a document filed with the SEC on Feb 24 that Mazzariello Gina (Chief Legal Officer) sold a total of 3,586 shares of the company’s common stock. The trade occurred on Feb 24 and was made at $34.49 per share for $0.12 million. Following the transaction, the insider now directly holds 37414.0 shares of the AMLX stock.

Still, SEC filings show that on Feb 23, Morningside Venture Investment (10% Owner) disposed off 50,000 shares at an average price of $35.57 for $1.78 million. The insider now directly holds 7,580,598 shares of Amylyx Pharmaceuticals Inc. (AMLX).

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts